• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » psychotherapy

Articles Tagged with ''psychotherapy''

Treating Tourette’s Disorder

March 1, 2017
Melissa Fluehr, Maxwell Luber, and Barbara Coffey, MD, MS
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Melissa Fluehr Clinical research coordinator, Behavioral Science Unit, Icahn School of Medicine at Mount Sinai, New York, NY. Ms. Fluehr has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity. Maxwell Luber Clinical research coordinator, Behavioral Science Unit, Icahn School of Medicine at Mount Sinai, New York, NY. Mr. Luber has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity. Barbara Coffey, MD, MS Director, National Tourette Center of Excellence, Icahn School of Medicine at Mount Sinai Dr. Coffey has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Tourette’s disorder (TD), also known as Tourette syndrome, is a fascinating yet complex neurodevelopmental disorder that can be challenging to treat. Dr. Georges Gilles de la Tourette, a French neurologist who described the first nine cases in 1885, had it right when he described the “peculiar” symptoms as a syndrome, later reporting that “fears, phobias, and arithmomania” were part of the picture.
Read More

From the Street to the Prescription Pad: Psychedelics Return to Psychiatry

March 1, 2017
Philip Wolfson, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Philip Wolfson, MD Director of The Center for Transformational Psychotherapy in San Anselmo, CA Dr. Wolfson has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
As marijuana has gained acceptance—it can now be prescribed to treat a wide variety of medical conditions in 28 states and Washington, DC—there has also been a shift in attitudes toward other mind-altering substances that, despite their reputation as drugs of abuse, show promise as therapeutic agents.
Read More

MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder

March 1, 2017
Shannon Clare Petitt, MA
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Shannon Clare Petitt, MA/ MDMA therapy training program manager at MAPS Public Benefit Corporation (MPBC), Santa Cruz, CA Ms. Petitt has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Ms. Petitt’s manages the program that selects and trains researchers for the MDMA-assisted psychotherapy protocols MAPS Public Benefit Corporation is conducting. The program has reviewed 300 applicants, and is in the midst of training 80 people who will work on therapy teams for Phase 3 trials. In addition to the training program, Ms. Petitt has also served as co-therapist on the MAPS-sponsored Phase 2 trial of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness.
Read More

Does CBT Improve Outcome in Buprenorphine Treatment?

March 1, 2017
Colleen Ryan, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Colleen Ryan, MD Dr. Ryan has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Patients receiving buprenorphine for opioid use disorder are typically also referred for psychotherapy, either individual or group. However, several studies have failed to show that therapy improves outcomes in buprenorphine treatment program
Read More

CME Post-Test - Street Drugs, CATR, March/April 2017

March 1, 2017
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 2 CME credits.
Read More

Pornography Addiction

January 1, 2017
Peter Kleponis, PhD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Peter Kleponis, PhDPeter Kleponis, PhD Comprehensive Counseling Services and The Institute for Marital Healing in Conshohocken, PA. Dr. Kleponis has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Pornography addiction is more of a process or behavioral addiction where the effect on the brain is the same, but you’re not putting a foreign chemical into your body. Pornography is just one behavior that we would put under that umbrella of sexual addiction. And for some people who become sex addicts, it actually starts out with pornography—as a sort of gateway drug.
Read More

Managing Pain: A Cognitive Behavioral Therapist’s Approach [Free Article]

October 26, 2016
John D. Otis, PhD
...
Read More

Evaluating and Treating Pain in Psychiatric Patients

September 28, 2016
...
Read More

Managing Pain: A Cognitive Behavioral Therapist’s Approach

September 28, 2016
John D. Otis, PhD
As a clinical psychologist with a specialty in chronic pain management, I am often referred patients with both chronic pain and psychiatric issues. Many of these patients see a psychiatrist and a therapist, and are taking with both psychotropic and pain medications. The referral is often made because there is...
Read More

Evaluating and Treating Pain in Psychiatric Patients

September 1, 2016
Michael Robert Clark, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Expert QA Author PictureMichael Robert Clark, MD Associate professor & director of the Chronic Pain Treatment Program at The Johns Hopkins Hospital in Baltimore, MD Dr. Clark discloses that he has been a paid consultant to Collegium Pharmaceutical Inc. and Depomed, Inc. Dr. Carlat has reviewed this article and has found no evidence of bias in this educational activity.
Many chronic pain patients are dealing with psychiatric problems. Pain patients have tremendously high rates of major depressive disorder which is undertreated and underdiagnosed. It's easy to assume that the depression is a reaction to living with chronic pain, but in fact it’s often the other way around. Dr. Michael Robert Clark describes evaluations and treatment methods clinicians can use to address pain management with their patients.
Read More
Previous 1 2 … 7 8 9 10 11 12 13 14 15 … 22 23 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • GFB1e_Spiral.png

    Geriatric Psychiatry Fact Book, First Edition (2025)

    Everything you need to help your older adult patients from the unbiased clinical experts who...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.